Position in EBS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$83,800
+$800 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#130
of 193 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Herold Advisors, Inc. holds $83,800 across 1 Drug Manufacturers - Specialty & Generic name. EBS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EBS |
Emergent BioSolutions Inc.
This page
|
10,000 | $83,800 |
All Filings in EBS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,800 | 10,000 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $83,000 | 10,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $123,600 | 10,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $88,200 | 10,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $63,800 | 10,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,600 | 10,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $95,600 | 10,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $83,500 | 10,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,200 | 10,000 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $25,300 | 10,000 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $24,000 | 10,000 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $34,000 | 10,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $73,500 | 10,000 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $103,600 | 10,000 | Shares | Sole | 2023-04-19 | |
| No filing history on record for this holder in this stock. | ||||||